Webinar: This Fall’s Medical Conferences
Research - A recording of last night’s strategy webinar is now available. Click here for the recording. Thanks to those of you who attended on a Thursday … Continue Reading
PremiumMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Product Improvements and a Trial Start at Bluebird Bio
Research - We’ve had some questions about this month’s Healthcare Huddle, which will take place on the 22nd(the third full-week Thursday in the month), and what topics … Continue Reading
Premium
CNS Is In the News: Updates from PropThink’s August Webinar
Research - A few quick updates from our CNS webinar last month. Sage Therapeutics (SAGE) announced that SAGE-547 has received Breakthrough Therapy Designation for Postpartum Depression based … Continue Reading
Premium
What Arbutus Needs for a Sea Change
Research - It was just over one year ago that Tekmira Pharmaceuticals (TKMR) changed its name to Arbutus Biopharma (ABUS), and its focus to HBV, moving away from … Continue Reading
Read now
Clinton Tweets, Drug Stocks Fall
Insights - Drug stocks tumbled across the board on Wednesday with Hillary Clinton’s latest jab at the industry, spurred by the current backlash against EpiPen-maker, Mylan (MYL). … Continue Reading
Read nowThe August ‘Healthcare Huddle’ Webinar is Here
zPremium - Thursday afternoon was our latest Healthcare Huddle webinar. We covered ongoing ideas, but focused afterwards on a slew of CNS-focused companies that are worth looking … Continue Reading
Premium
Clearly, SRSE is Sage’s Biggest Event
Research - Shares of Sage Therapeutics (SAGE) fell today on news that data from STATUS — the company’s phase 3 study of SAGE-547 in SRSE – would … Continue Reading
Premium